RELY:NASDAQRemitly Global, Inc. Analysis
Data as of 2026-07-08 - not real-time
$23.24
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Remitly (RELY) is trading at $23.24, comfortably above its 20‑day and 50‑day SMAs ($21.30 and $21.53) and the 200‑day SMA ($16.77), while still below the identified resistance at $24.81, suggesting room for upside. The RSI of 61.7 and a bullish MACD histogram (+0.32) indicate continued momentum, though volume is trending lower and 30‑day volatility is high at 46.7%, reflecting a relatively choppy market. The stock’s forward PE of 14.1 is well below its trailing PE of 48.4 and the industry average PE of 33.4, and the DCF‑derived fair value of $34.02 implies an upside of roughly 23% from current levels. Revenue is growing at 25% YoY with a solid 60.8% gross margin and operating margin of 14.4%, while free cash flow remains healthy at $181.7 M and cash on hand exceeds debt by a wide margin. Analysts are overwhelmingly positive, with a “strong buy” consensus, a median price target of $28 and an “extreme greed” market sentiment. Recent news reinforces this bias: earnings beats, a 3.1% share jump on macro‑driven optimism, and reaffirmed overweight ratings from Cantor Fitzgerald highlight strong transfer growth and confidence in the fintech narrative.
Given the blend of strong top‑line growth, improving profitability, ample liquidity, and a valuation gap to intrinsic value, the stock appears positioned for continued appreciation. However, the high beta (≈1.3) and elevated short‑term volatility warrant caution, especially as volume declines and regulatory scrutiny on cross‑border payments intensifies. The overall picture is one of a growth‑oriented fintech that is currently undervalued relative to its fundamentals and forward outlook.
Given the blend of strong top‑line growth, improving profitability, ample liquidity, and a valuation gap to intrinsic value, the stock appears positioned for continued appreciation. However, the high beta (≈1.3) and elevated short‑term volatility warrant caution, especially as volume declines and regulatory scrutiny on cross‑border payments intensifies. The overall picture is one of a growth‑oriented fintech that is currently undervalued relative to its fundamentals and forward outlook.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 8/10
Key Factors
- Bullish MACD and RSI indicating upward momentum
- Price below resistance with technical support intact
- Positive analyst sentiment and recent earnings beat
Medium Term
1–3 yearsPositive
Model confidence: 9/10
Key Factors
- Forward PE of 14.1 vs trailing PE of 48.4 suggests re‑rating
- Revenue growth of 25% and expanding profit margins
- DCF fair value implies ~23% upside to target range
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Large TAM for digital cross‑border payments
- Strong cash position and low net debt
- Sustained analyst “strong buy” consensus and upward price targets
Key Metrics & Analysis
Financial Health
Revenue Growth25.20%
Profit Margin6.12%
P/E Ratio48.4
ROE12.95%
ROA6.56%
Debt/Equity4.33
P/B Ratio5.4
Op. Cash Flow$326.2M
Free Cash Flow$181.7M
Industry P/E33.4
Technical Analysis
TrendNeutral
RSI61.7
Support$17.70
Resistance$24.81
MA 20$21.30
MA 50$21.53
MA 200$16.77
MACDBullish
VolumeDecreasing
Fear & Greed Index91.45
Valuation
Fair Value$34.02
Target Price$28.56
Upside/Downside22.87%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta1.29
Volatility46.71%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.